A61K36/47

ANTI-CANCER AND ANTI-PROLIFERATIVE COMPOSITIONS, AND METHODS FOR THEIR USE IN TREATING CANCER
20220233624 · 2022-07-28 · ·

The present invention is directed to methods of treating cancer and inhibiting proliferation of cancer cells with compositions comprising extracts prepared from Terminalia chebula fruits (for instance AyuFlex®), Terminalia bellerica fruits (for instance Ayuric®), Phyllanthus emblica fruits (for instance Capros®), Withania somnifera roots and leaves (for instance Sensoril®), Shilajit (for instance PrimaVie®), Azadirachta indica leaves and twigs (for instance PhytoBGS®), and/or combinations thereof, including a trivalent chromium complex with extracts of Shilajit and P. emblica (e.g. Crominex-3+®). Combinations of the extracts with anti-cancer drugs, and related methods, are also described.

PERSONAL AND HOME CARE COMPOSITIONS COMPRISING FATTY ACIDS FROM TUNG SEED OIL AS ANTIMICROBIAL PRESERVATIVE

Disclosed herein are personal care and home care composition comprising the whole of fatty acids (unfractionated) of Tung seed oil (Aleurites fordii, Vernicia fordii (family:Euphorbiaceae) as an antimicrobial preservative. The invention further discloses process of preparation of such compositions having fatty acids of Tung seed oil which are produced by saponification of commercially available Tung oil from seeds of the nuts of Tung tree. The home and personal care compositions comprising ‘whole’ mixture of fatty acids derived from the corresponding triglyceride oil at concentration of 0.5 to 2% w/w of the total composition help preserve the composition without any additional antimicrobial preservatives.

NEUROPROTECTIVE PHYLLANTHUS EMBLICA-CONTAINING COMPOSITIONS AND METHODS

This invention is directed to methods of attenuating brain injury and providing neuroprotection to the brain from injury such as from stroke, by administering compositions containing extracts of Phyllanthus emblica; and related methods.

TREATMENT OF CORONAVIRUS AND BACTERIAL INFECTION WITH HOUTTUYNIA CORDATA EXTRACT AND COMBINED HOUTTUYNIA CORDATA AND PHYLLANTHUS URINARIA
20230270813 · 2023-08-31 ·

A method for treating coronavirus infection and bacterial infection in a subject in need thereof, including: applying to the subject a topical solution containing a therapeutically effective amount of Phyllanthus urinaria (PU) extract or one of its physiologically acceptable forms; and administering to the subject a composition comprising a therapeutically effective amount of Houttuynia cordata (HC) extract or one of its physiologically acceptable forms.

Medicinal composition of amaranth origin for cardiovascular treatment
11338005 · 2022-05-24 · ·

A medicinal composition having a nitrate enriched extract of Amaranth for the prevention and treatment of myocardial ischemia-reperfusion injury, and for the improvement of cardioprotective health and cardio renal protection. A method for the prevention and treatment of myocardial ischemia-reperfusion injury, method of improving cardioprotective health and cardio renal protection by using the composition having a nitrate enriched extract of Amaranth.

Medicinal composition of amaranth origin for cardiovascular treatment
11338005 · 2022-05-24 · ·

A medicinal composition having a nitrate enriched extract of Amaranth for the prevention and treatment of myocardial ischemia-reperfusion injury, and for the improvement of cardioprotective health and cardio renal protection. A method for the prevention and treatment of myocardial ischemia-reperfusion injury, method of improving cardioprotective health and cardio renal protection by using the composition having a nitrate enriched extract of Amaranth.

METHODS, COMPOSITIONS, AND DELIVERY SYSTEMS FOR THERAPEUTIC SKIN TREATMENTS
20220151882 · 2022-05-19 ·

Disclosed are skincare formulations, delivery systems and treatment methods containing an oligopeptide and a combination of antioxidants for topical application to the skin before and/or after dermatological procedures that affect the skin's barrier. The systems herein alleviate discomfort and enable rapid healing of irritated and damaged skin, and provide improved treatment outcomes for dermatological procedures. The disclosed topical formulations, delivery systems, and methods thereof provide enhanced penetration of the active ingredients to the skin while maintaining skin moisture and protecting sensitive skin after dermatological procedures for improvement of aesthetic skin properties. Also provided are methods for therapeutic treatment of dermatological conditions by topically applying, using, for example, a pre-moistened bio-cellulose mask, a formulation comprising (% w/w) at least 0.0001% palmitoyl sh-tripeptide-4 amide on an active basis and at least 0.1% Camellia sinensis leaf extract.

METHODS, COMPOSITIONS, AND DELIVERY SYSTEMS FOR THERAPEUTIC SKIN TREATMENTS
20220151882 · 2022-05-19 ·

Disclosed are skincare formulations, delivery systems and treatment methods containing an oligopeptide and a combination of antioxidants for topical application to the skin before and/or after dermatological procedures that affect the skin's barrier. The systems herein alleviate discomfort and enable rapid healing of irritated and damaged skin, and provide improved treatment outcomes for dermatological procedures. The disclosed topical formulations, delivery systems, and methods thereof provide enhanced penetration of the active ingredients to the skin while maintaining skin moisture and protecting sensitive skin after dermatological procedures for improvement of aesthetic skin properties. Also provided are methods for therapeutic treatment of dermatological conditions by topically applying, using, for example, a pre-moistened bio-cellulose mask, a formulation comprising (% w/w) at least 0.0001% palmitoyl sh-tripeptide-4 amide on an active basis and at least 0.1% Camellia sinensis leaf extract.

CROTON LECHLERI COMPOSITIONS FOR USE IN THE TREATMENT OF SKIN CANCER

The present disclosure provides for the treatment of precancerous or cancerous skin lesions via the topical administration of a pharmaceutical composition comprising a therapeutically effective amount of an extract of the Croton lechleri tree. Also provided are details of studies on the effectiveness of an extract of the Croton lechleri tree on precancerous or cancerous skin lesions.

CROTON LECHLERI COMPOSITIONS FOR USE IN THE TREATMENT OF SKIN CANCER

The present disclosure provides for the treatment of precancerous or cancerous skin lesions via the topical administration of a pharmaceutical composition comprising a therapeutically effective amount of an extract of the Croton lechleri tree. Also provided are details of studies on the effectiveness of an extract of the Croton lechleri tree on precancerous or cancerous skin lesions.